Genomics and patient selection in the treatment of mPCa patients
In this interview from UROonco24, Dr. Juan Gómez Rivas (ES) and Dr. Ursula Vogl (CH) discuss advancements in genomic profiling and the use of PARP inhibitors in treating metastatic prostate cancer, wi...
3 Marras 20249min
Dr. Skøtt talks about approaches to managing primary obstructive megaureter in children
In this episode, Dr. Martin Stentebjerg Skøtt (DK) presents findings from a recently published systematic review on the topic of "Endoscopic balloon dilatation and incision for treating primary obstru...
26 Loka 20245min
The role of urologists in the treatment of mPCa patients
In this interview, medical oncologist Dr. Elena Castro (ES) and Dr. Gianluca Giannarini (IT) discuss the challenges of managing treatment-related toxicity and quality of life for PCa patients, particu...
19 Loka 20249min
Quality of life for mPCa patients undergoing treatment
In this interview recorded at UROonco24 in Budapest earlier in the year, Dr. Gianluca Giannarini (IT) talks with Prof. Geert De Meerleer (BE) about the quality of life for patients with metastatic pro...
12 Loka 202410min
Dr. Checcucci and Ass. Prof. Puliatti discuss new tech and standardisation trends in surgical training
In 'Episode 3' of the series "Voices of tomorrow's urologists (ESRU): Journeying through Europe's resident perspectives", Dr. Enrico Checcucci (IT) and Assoc. Prof. Stefano Puliatti (IT) discuss "Surg...
5 Loka 202415min
Dr. Vogl discusses the role of genetic testing for prostate cancer
This EAU podcast has been developed with financial support from Pfizer Inc for healthcare professionals based in the EU and UK. The content discussed here was up to date at the time of recording in Ju...
28 Syys 202412min
ESMO 2024 special: Prof. Kitamura shares results of JCOG1019 (BCa)
In this podcast recorded live at ESMO 2024 in Barcelona, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talked to Prof. Hiroshi Kitamura (JP) about his presentation on the JCOG1019 study results: ...
26 Syys 202410min
ESMO 2024 special: Results of interim analysis of SunRISe-4
UROONCO BCa chief editor Dr. Benjamin Pradere talks to Assoc. Prof. Andrea Necchi (IT) at EMSO 2024 on the results of the interim analysis of SunRISe-4 study: TAR-200 plus cetrelimab or CET alone as n...
26 Syys 202410min
